ReviewMolecular diversity2026
Plant-derived coumarins: emerging natural scaffolds for antidiabetic drug discovery.
Review in Molecular diversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diabetes mellitus is a leading global health problem, with type 2 diabetes being the main type and already very inefficient treatments posing a challenge. Plant-based compounds, especially those that are naturally occurring have become very popular lately and are regarded as major sources of new antidiabetic drugs owing to the diversity of their structures and the fact that they act on multiple targets at the same time. One of these groups of compounds is coumarins, which have proved to be an important class of bioactive substances with considerable antidiabetic properties. The review that we are presenting gives an inclusive report on the occurrence of natural coumarins and their derivatives with antidiabetic activity being reported, along with the discussion of their mechanisms of action that include among others the inhibition of the enzymes that digest carbohydrates, increase of the insulin sensitivity, regulation of the glucose uptake, protection of the pancreatic β-cells and regulation of oxidative stress and inflammation. Also, the structure-activity relationships of coumarin derivatives are discussed to bring out the important functional features that are responsible for the biological activity. Moreover, the latest developments in drug design, molecular docking studies and the therapeutic prospects of coumarin-based antidiabetic agents have been reviewed. Overall, this review has pointed out the plant-based coumarins as being very versatile scaffolds in the development of antidiabetic therapeutics that are both safe and effective with fewer side effects.
Indexed as
Identifiers
41678083What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.